About Bioke
Bioke is a company based in Leiden (Netherlands) founded in 2004. Bioke operates in a competitive market with competitors including Abcam, Arbor Biotechnologies, Stem Cell Technologies, Singleron and Octant, among others.
- Latest Funding Round$59.71K (USD), Grant
May 2016
- Investors
Funding Insights of Bioke
- Total Rounds 4
- Last Round Grant — $59,708
- Investors Count 1
All 4 funding rounds of Bioke with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2016 | $59,708 | Grant | – | – | |
| Jul 2015 | $16,512 | Grant | – | – | |
| Jun 2015 | $11,907 | Grant | – | – | |
| Jan 2014 | – | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Bioke
Bioke has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Bioke
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bioke
3 dated milestones of Bioke across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Bioke is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $60K.
Competitors of Bioke
Bioke operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Arbor Biotechnologies, Stem Cell Technologies, Singleron and Octant, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| arbor.bio | 2016 | Cambridge, United States | $304.1M | 117 | Genomic technologies and drug discovery platforms are provided. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| singleron.bio | 2018 | Hagen, Germany | $84.48M | – | Developer of single-cell multi-omics platform for clinical research and molecular diagnosis | |
| octant.bio | 2017 | Los Angeles, United States | $110M | 63 | Human cell interaction platform is provided for drug discovery. | |
| diagenode.com | 2003 | Seraing, Belgium | $8.45M | 99 | Reagents and kits for epigenetics sequencing solutions are developed. | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. |
Detailed competitors of Bioke
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bioke
The website of Bioke (bioke.com) receives about 15.2K visits a month.
- Monthly visits15.2K
▼ 8.2% vs previous month
Websites whose visitors overlap most with Bioke. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biosearchtech.com | 100% | 52K | #598,672 | View details | |
enzolifesciences.com | enzolifesciences.com | 88% | – | – | – |
| mclab.com | 88% | – | #2,661,746 | View details | |
| cellsignal.com | 83% | 488.2K | #114,694 | View details | |
| citeab.com | 75% | 601.8K | #63,627 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 25 similar websites and full traffic analytics for Bioke
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Bioke
Complete news archive for Bioke
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Bioke
10 companies that operate in the same segment as Bioke (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioke
Bioke was founded in 2004 and raised its 1st funding round 10 years after it was founded.
Bioke is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
Bioke was founded in 2004 in Leiden, Netherlands, within the biotechnology sector. Reagents and kits for research applications are developed, alongside instruments for sample preparation in next-generation sequencing, PCR, digital PCR, real-time PCR, and quantification of DNA, RNA, and proteins. The portfolio extends to single-cell template generation for gene expression and sequencing, genotyping, heat sealing, cellular biology tools, cell storage systems, and high-throughput chromatin and DNA shearing.
Bioke's top competitors include Abcam, Arbor Biotechnologies and Singleron.
Bioke has 1 investor. Key investors include European Union.